Synapse

← Jurriën M. ten Berg

Papers by Jurriën M. ten Berg

Page 7 · newest first

  1. New bioabsorbable septal repair implant for percutaneous closure of a patent foramen ovale: Short‐term results of a single‐centre experienceCatheterization and Cardiovascular Interventions · 2009
  2. The influence of clinical characteristics, laboratory and inflammatory markers on ‘high on-treatment platelet reactivity’ as measured with different platelet function testsThrombosis and Haemostasis · 2009
  3. Intracoronary infusion of autologous mononuclear bone marrow cells in patients with acute myocardial infarction treated with primary PCI: Pilot study of the multicenter HEBE trialCatheterization and Cardiovascular Interventions · 2008
  4. The use of the VerifyNowsystem to monitor antiplatelet therapy: A review of the current evidencePlatelets · 2008
  5. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrelThrombosis and Haemostasis · 2008
  6. One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trialEuropean Heart Journal · 2007
  7. Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathyAJP Heart and Circulatory Physiology · 2007
  8. Monitoring Antiplatelet Therapy with Point-of-Care Platelet Function Assays: A Review of the EvidenceFuture Cardiology · 2007
  9. Ongoing tirofiban in myocardial infarction evaluation (On-TIME) 2 trial: rationale and study designEuroIntervention · 2007
  10. Double‐Trouble: Three Cases with Simultaneous Stent Thrombosis in Different Coronary ArteriesJournal of Interventional Cardiology · 2007
  11. To adjust or not to adjust the platelet count in light transmission aggregometry in patients receiving dual aspirin/clopidogrel treatmentPlatelets · 2007
  12. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysisEuropean Heart Journal · 2006
  13. Age-Dependent Effect of Abciximab in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary InterventionsCirculation · 2006
  14. Early Onset and Progression of Left Ventricular Remodeling After Alcohol Septal Ablation in Hypertrophic Obstructive CardiomyopathyCirculation · 2005
  15. One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel†European Heart Journal · 2005
  16. A Clinical Trial of Abciximab in Elective Percutaneous Coronary Intervention after Pretreatment with ClopidogrelNew England Journal of Medicine · 2004
  17. Stenting for Restenotic Lesions with the BARD XT StentJournal of Interventional Cardiology · 2003
  18. Pretreatment with Oral Anticoagulants Decreases Platelet Activation in Patients Before and After Percutaneous Coronary InterventionThrombosis and Haemostasis · 2002
  19. Patent foramen ovale causing position-dependent shunting in a patient, when laying down her corsetEuropean Respiratory Journal · 2001
  20. Oral Anticoagulant Therapy During and After Coronary AngioplastyCirculation · 2001
  21. Effect of Coumarins Started Before Coronary Angioplasty on Acute Complications and Long-Term Follow-UpCirculation · 2000
  22. Hypertrophic obstructive cardiomyopathy. Initial results and long-term follow-up after Morrow septal myectomy.Circulation · 1994
  23. Initial and long‐term results of percutaneous transluminal coronary angioplasty in patients 75 years of age and olderCatheterization and Cardiovascular Diagnosis · 1992